Navigation Links
Solazyme Announces New Senior Vice President of Business Development
Date:10/3/2007

Troy J. Campione, Ph.D., Joins Solazyme Executive Team

SOUTH SAN FRANCISCO, Calif., Oct. 3 /PRNewswire/ -- Solazyme, a bioscience company pioneering biofuels and health/wellness products from microalgae, has named Troy J. Campione, Ph.D., to the position of senior vice president of business development.

Campione will lead the development, negotiation, and finalization of partnership agreements and contracts with major companies. These deals will help fund research and development programs leveraging Solazyme's work on biofuels and industrial chemicals.

Campione has extensive experience monetizing technology across diverse industries and geographies. Most recently he was general manager and vice president of Symyx Technologies, Inc., a company providing high throughput research and informatics technologies globally to the chemical, energy, polymer, pharmaceutical, and electronics industries. At Symyx, he was accountable for collaborative research, strategic alliances, and materials licensing. During his tenure, Campione leveraged the company's technology position to negotiate more than $400 million of new research services, products, and licensing revenues with major chemical and energy companies including ExxonMobil, Dow Chemical, BP, Ineos, Innovene, and Celanese.

"Troy's breadth of experience in developing strategic alliances along with his talent for licensing technologies will enhance our ability to develop relationships with potential partners as we commercialize our algal-based technologies," said Jonathan Wolfson, president and chief operating officer of Solazyme. "We are extremely excited to have him join our management team."

Prior to Symyx, Campione spent 15 years at ExxonMobil in business, research and development, and technology management positions in Houston, Baytown, and Baton Rouge. He led the research and development activities for advanced catalyst and process technologies as worldwide basic chemicals technology manager, delivered continued success and growth of the vinyl intermediates area as its business manager, and prioritized, championed, and secured significant chemical plant expansions for the intermediates business of Exxon Chemical.

Campione earned his Ph.D. in chemical engineering from the University of Texas at Austin and also holds M.E. and B.S degrees in Chemical Engineering from Tulane University.

About Solazyme:

Founded in 2003 and headquartered in South San Francisco, California, Solazyme is a leading biotechnology company focused on the engineering and optimization of algae for production of biofuels and health and wellness materials. For more information, please visit our website: http://www.solazyme.com.

For More Information Contact:

Jackie Kolek Ellen Snook

Peppercom Peppercom

212-931-6166 415-438-9821

jkolek@peppercom.com esnook@peppercom.com


'/>"/>
SOURCE Solazyme
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)...  In the pharmaceutical industry the medical affairs function ... activities including the identification and engagement of key thought ... high in the oncology therapeutic area where most treating ... Role of Medical Affairs in Oncology Launch Excellence ." ... find better ways to utilize medical affairs to develop ...
(Date:2/5/2016)... , February 5, 2016 ... a biotechnology company focused on developing products for Regenerative ... requested Rare Pediatric Disease Designation (RPDD) from the US ... (RP) with MANF. MANF was previously granted orphan drug ... --> Amarantus BioScience Holdings, Inc. ...
(Date:2/4/2016)... (PRWEB) , ... February 04, 2016 , ... ... talent development and compliance training, today announced an interactive FDA compliance training ... The RAPS (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now ...
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Sangamo BioSciences, ... genome editing, announced today that Edward Lanphier , ... update on the progress of Sangamo,s ZFP Therapeutic ® ... business strategy at 2:40 pm ET on Thursday, February ... Annual Global Healthcare Conference. The conference is being held ...
Breaking Biology Technology:
(Date:1/8/2016)... LOS ANGELES and MANCHESTER, United Kingdom ... ("BBI"), a developer of innovative sensor-based diagnostic products, today ... was financed by new and existing investors.  Proceeds from the ... SEM Scanner , a hand-held device for detecting early-stage ... and Ireland after receiving CE Mark ...
(Date:1/7/2016)... -- This BCC Research report studies the global as ... identifying newer markets and exploring the expansion of the ... Includes forecast from 2015 to 2020. Use ... the expansion of the present application market for various ... technology, determine its current market size, and estimate the ...
(Date:1/7/2016)...  A United States District Court in ... country to interpret a biometric privacy statute in a ... the photo website Shutterfly brought by the law firm Carey ... vs. SHUTTERFLY, INC.; and THISLIFE, INC ( N.D. Ill ... the Illinois Biometric Privacy Act by collecting and scanning ...
Breaking Biology News(10 mins):